NEW YORK (GenomeWeb) — Finnish diagnostics firm Mobidiag said today that it received CE-IVD marking for its Novodiag CarbaR+ test for carbapenemase-producing enterobacteriaceae (CPE), a bacteria resistant to carbapenem antibiotics.

The multiplex qPCR- and microarray-based test detects CPE and associated resistance markers, as well as a plasmid-mediated resistance for colistin, a last-resort antibiotic for many infections. It runs on the company's automated Novodiag system and produces results within 80 minutes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.